Exo Imaging, Inc.

Exo is a commercial-stage company that developed the Iris handheld ultrasound system, integrating proprietary piezoelectric micromachined ultrasonic transducer (pMUT) technology, artificial intelligence, and cloud-connected workflow software to enable high-quality, portable medical imaging for both diagnostic and emerging therapeutic applications. Their AI tools are FDA-cleared for bladder volume, hip dysplasia, and thyroid nodule assessment, with additional solutions for cardiac and lung assessment under regulatory review. The platform is designed for use by both experts and minimally trained caregivers in diverse clinical and remote settings.